Egypt Ranks 38th Globally in COVID-19 Resilience Ranking

Egypt has been ranked 38th globally in the COVID-19 resilience ranking issued by Bloomberg, after climbing 10 places in April, up from 47th spot in January.

This came thanks to the country's ability to withstand the pandemic, in the light of the ongoing national vaccination program, after receiving 680 thousand doses of Sinopharm vaccine and 854 thousand doses of the AstraZeneca vaccine, in coordination with the COVAX global initiative, run by the Gavi Alliance.

It is also expected that the state-owned Vaxira company will produce about 5 million doses of the Chinese Sinovac vaccine locally within two months, before raising production capacity to between 40 and 60 million doses annually.

The ranking measured the ability of countries to combat the pandemic and determined the best countries to live in during the crisis as per 10 sub-indicators, including, monthly cases, monthly fatality rate, total deaths per 1million, positive test rates, access to COVID-19 vaccines, lockdown severity, community mobility, 2020 GDP growth forecast, universal healthcare coverage, and human development index.

New Zealand, Singapore, and Australia snagged the top three spots, while Poland and Mexico came at the bottom of the list.